Skip to main content
SB23-271

Intoxicating Cannabinoid Hemp And Marijuana

Type Bill
Session 2023 Regular Session
Subjects
Business & Economic Development Liquor, Tobacco, & Marijuana

Concerning the regulation of compounds that are related to cannabinoids, and, in connection therewith, making an appropriation.

Bill Summary:

Colorado law requires the manufacturer of cosmetic products, dietary supplements, food products, and food additives, including hemp products, to be registered with the department of public health and environment (department).

The act creates a new framework for the department to regulate and register hemp products and certain intoxicating hemp products and for the marijuana enforcement division (division) in the department of revenue to regulate intoxicating products or potentially intoxicating compounds that are or may be cannabinoids. This regulation includes:

  • The power to promulgate rules authorizing or prohibiting chemical modification, conversion, or synthetic derivation to create certain types of intoxicating cannabinoids;
  • Classifying and reclassifying cannabinoids as intoxicating, potentially intoxicating, or nonintoxicating;
  • Labeling and advertising requirements;
  • Production and testing requirements;
  • Inspection, record-keeping, surveillance, and inventory tracking requirements;
  • Prohibiting the export of a safe harbor hemp product that is a synthetic cannabinoid or that is being exported to a state where it is illegal; and
  • Issuing a cease-and-desist order or clean-up order.
Hemp- and marijuana-derived compounds and cannabinoids are classified into 3 classifications:

  • Nonintoxicating cannabinoids;
  • Potentially intoxicating cannabinoids; and
  • Intoxicating cannabinoids.
Nonintoxicating cannabinoids that are derived from hemp may be produced, distributed, or sold as a hemp product. With the exception of products manufactured or produced for export, which are referred to as "safe harbor hemp products" and with some exceptions for small amounts of THC, products containing potentially intoxicating compounds and intoxicating cannabinoids must only be produced, distributed, or sold by a person licensed by the division to produce, distribute, or sell the compound or cannabinoid as a product.

The act clarifies that:

  • Nonintoxicating cannabinoids, potentially intoxicating compounds, and intoxicating cannabinoids are marijuana or marijuana products for the purposes of the retail marijuana sales tax; and
  • A person must be licensed by the division to manufacture potentially intoxicating compounds or intoxicating cannabinoids.
The act prohibits the following acts:

  • Manufacturing, selling, or delivering products that contain intoxicating cannabinoids in excess of limits established by rule;
  • Manufacturing a product containing hemp that is not a cosmetic, a dietary supplement, a food, a food additive, or an herb;
  • Manufacturing, producing, selling, distributing, or holding for sale or distribution a safe harbor hemp product without registering with the department;
  • Selling a hemp product to an individual who is under 21 years of age if the hemp product has a ratio of cannabidiol to tetrahydrocannabinol (THC) of less than 20:1 and the hemp product contains more than 1.25 milligrams of THC, but this prohibition does not apply to products with no THC, tinctures, cosmetics, or hemp products that the United States food and drug administration has determined are generally recognized as safe;
  • Selling a hemp product in a container with more than 5 servings if the hemp product has more than 1.25 milligrams of THC and a ratio of cannabidiol to THC of less than 20:1, but this prohibition does not apply to products with no THC, tinctures, cosmetics, or hemp products that the United States food and drug administration has determined are generally recognized as safe; or
  • Selling a hemp product in a container with more than 30 servings if the hemp product has more than 1.25 milligrams of THC and a ratio of cannabidiol to THC of 20:1 or more, but this prohibition does not apply to products with no THC, tinctures, cosmetics, or hemp products that the United States food and drug administration has determined are generally recognized as safe.
The penalty for a violation is up to $10,000 per day per violation. The act specifies factors to consider in determining the amount of the penalty.

The act requires the executive director of the department of revenue to analyze the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication. The department of revenue may engage experts to inform its analysis.

The bill sets standards for marijuana cultivation facilities to buy seeds and clones.

To implement this act:

  • $1,574,061 is appropriated to the department. This appropriation consists of $1,168,485 from the general fund and $405,576 from the wholesale food manufacturing and storage protection cash fund;
  • $295,024 is appropriated from the general fund to the marijuana cash fund and reappropriated from the marijuana cash fund to the department of revenue; and
  • Of the amounts appropriated to the departments of public health and environment and revenue, $437,764 is reappropriated to the department of law for the provision of legal services to those departments.
The amounts are appropriated to the departments for the 2023-24 state fiscal year, and the departments are authorized to spend any amount not expended in the 2023-34 state fiscal year in the 2024-25 state fiscal year for the same purposes.

APPROVED by Governor June 7, 2023

EFFECTIVE June 7, 2023
(Note: This summary applies to this bill as enacted.)

Status

Became Law

Introduced

Passed

Became Law

Related Documents & Information

Date Version Documents
06/07/2023 Signed Act PDF
05/17/2023 Final Act PDF
05/07/2023 Rerevised PDF
05/06/2023 Revised PDF
04/27/2023 Reengrossed PDF
04/26/2023 Engrossed PDF
04/06/2023 Introduced PDF
Date Version Documents
05/06/2023 PA3 PDF
04/24/2023 PA2 PDF
04/19/2023 PA1 PDF
Date Version Documents
07/18/2023 FN3 PDF
04/21/2023 FN2 PDF
04/17/2023 FN1 PDF
Date Version Documents
05/03/2023 SA2 PDF
04/23/2023 SA1 PDF
Activity Vote Documents
Adopt amendment J.003 The motion passed without objection. Vote summary
Refer Senate Bill 23-271, as amended, to the Committee of the Whole. The motion passed on a vote of 9-1. Vote summary
Activity Vote Documents
Refer Senate Bill 23-271 to the Committee on Appropriations. The motion passed on a vote of 11-0. Vote summary
Activity Vote Documents
Adopt amendment J.001 The motion passed without objection. Vote summary
Refer Senate Bill 23-271, as amended, to the Committee of the Whole. The motion passed on a vote of 7-0. Vote summary
Activity Vote Documents
Adopt amendment L.002 (Attachment B) The motion passed on a vote of 5-2. Vote summary
Adopt amendment L.007 (Attachment C) The motion passed without objection. Vote summary
Adopt amendment L.006 (Attachment D) The motion passed without objection. Vote summary
Adopt amendment L.008 (Attachment E) The motion failed on a vote of 3-4. Vote summary
Refer Senate Bill 23-271, as amended, to the Committee on Appropriations. The motion passed on a vote of 6-1. Vote summary
Date Calendar Motion Vote Vote Document
05/08/2023 Conference Committee Report REPASS
43
AYE
2
NO
20
OTHER
Vote record
05/08/2023 Conference Committee Report ADOPT
43
AYE
2
NO
20
OTHER
Vote record
05/07/2023 Third Reading BILL
61
AYE
2
NO
2
OTHER
Vote record
05/07/2023 Third Reading AMD (L.035)
53
AYE
10
NO
2
OTHER
Vote record
05/07/2023 Third Reading PERM
50
AYE
13
NO
2
OTHER
Vote record
Date Calendar Motion Vote Vote Document
05/08/2023 Conference Committee Report REPASS
35
AYE
0
NO
0
OTHER
Vote record
05/08/2023 Conference Committee Report ADOPT CCR
35
AYE
0
NO
0
OTHER
Vote record
05/08/2023 House Amendments NOT CONCUR APPT CC
35
AYE
0
NO
0
OTHER
Vote record
04/27/2023 Third Reading BILL
34
AYE
1
NO
0
OTHER
Vote record
Date Amendment Number Committee/ Floor Hearing Status Documents
05/07/2023 L.035 Third Reading Passed PDF
05/06/2023 L.030 Second Reading Passed [**] PDF
05/06/2023 L.029 Second Reading Passed [**] PDF
05/06/2023 L.028 Second Reading Passed [**] PDF
05/06/2023 L.027 Second Reading Passed [**] PDF
05/06/2023 L.026 Second Reading Passed [**] PDF
05/06/2023 L.024 Second Reading Passed [**] PDF
05/06/2023 L.023 Second Reading Passed [**] PDF
05/06/2023 L.032 Second Reading Passed [**] PDF
05/06/2023 L.022 Second Reading Lost [**] PDF
05/06/2023 L.020 Second Reading Passed [**] PDF
05/06/2023 L.019 Second Reading Passed [**] PDF
05/04/2023 J.003 HOU Appropriations Passed [*] PDF
04/26/2023 L.017 Second Reading Passed [**] PDF
04/26/2023 L.015 Second Reading Passed [**] PDF
04/26/2023 L.014 Second Reading Passed [**] PDF
04/26/2023 L.012 Second Reading Passed [**] PDF
04/26/2023 L.011 Second Reading Passed [**] PDF
04/26/2023 L.010 Second Reading Passed [**] PDF
04/24/2023 J.001 SEN Appropriations Passed [*] PDF
04/18/2023 L.008 SEN Finance Lost PDF
04/18/2023 L.006 SEN Finance Passed [*] PDF
04/18/2023 L.007 SEN Finance Passed [*] PDF
04/18/2023 L.002 SEN Finance Passed [*] PDF
Date Location Action
06/07/2023 Governor Governor Signed
05/17/2023 Governor Sent to the Governor
05/17/2023 Senate Signed by the President of the Senate
05/16/2023 House Signed by the Speaker of the House
05/08/2023 House House Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass
05/08/2023 ConfComm First Conference Committee Result was to Adopt Rerevised w/ Amendments
05/08/2023 Senate Senate Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass
05/08/2023 Senate Senate Considered House Amendments - Result was to Not Concur - Request Conference Committee
05/07/2023 House House Third Reading Passed with Amendments - Floor
05/06/2023 House House Second Reading Special Order - Passed with Amendments - Committee, Floor
05/04/2023 House House Second Reading Special Order - Laid Over Daily - No Amendments
05/04/2023 House House Committee on Appropriations Refer Amended to House Committee of the Whole
05/01/2023 House House Committee on Finance Refer Unamended to Appropriations
04/27/2023 House Introduced In House - Assigned to Finance
04/27/2023 Senate Senate Third Reading Passed - No Amendments
04/26/2023 Senate Senate Second Reading Passed with Amendments - Committee, Floor
04/24/2023 Senate Senate Committee on Appropriations Refer Amended to Senate Committee of the Whole
04/18/2023 Senate Senate Committee on Finance Refer Amended to Appropriations
04/06/2023 Senate Introduced In Senate - Assigned to Finance
Effective Date Chapter # Title Documents
06/07/2023 444 Intoxicating Cannabinoid Hemp & Marijuana PDF